Cas:954228-62-7 5-Bromo-N-isopropyl-3-nitropyridin-2-amine manufacturer & supplier

We serve Chemical Name:5-Bromo-N-isopropyl-3-nitropyridin-2-amine CAS:954228-62-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Bromo-N-isopropyl-3-nitropyridin-2-amine

Chemical Name:5-Bromo-N-isopropyl-3-nitropyridin-2-amine
CAS.NO:954228-62-7
Synonyms:5-bromo-3-nitro-N-propan-2-ylpyridin-2-amine
Molecular Formula:C8H10BrN3O2
Molecular Weight:260.08800
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:70.74000
Exact Mass:258.99600
LogP:3.16880

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-bromo-3-nitro-N-propan-2-ylpyridin-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-3-nitro-N-propan-2-ylpyridin-2-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-3-nitro-N-propan-2-ylpyridin-2-amine Use and application,5-bromo-3-nitro-N-propan-2-ylpyridin-2-amine technical grade,usp/ep/jp grade.


Related News: Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database. 5-Bromo-N-isopropyl-3-nitropyridin-2-amine manufacturer In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China. 5-Bromo-N-isopropyl-3-nitropyridin-2-amine supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 5-Bromo-N-isopropyl-3-nitropyridin-2-amine vendor At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. 5-Bromo-N-isopropyl-3-nitropyridin-2-amine factory No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel.